SurvivorNet on MSN10mon
New Drug for Myelodysplastic Syndrome Advances Towards FDA Approval — What is it, Who Can benefit & What You Need to KnowThere’s some promising news for people living with myelodysplastic syndrome (MDS) as a new treatment option may reduce the ...
Emavusertib hydrochloride is under clinical development by Curis and currently in Phase II for Myelodysplastic Syndrome.
Trecondyv is under clinical development by medac and currently in Pre-Registration for Myelodysplastic Syndrome.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback